+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?



Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?



Strahlentherapie und Onkologie 189(1): 54-61



To explore a new positron emission tomography (PET)-based target concept for pediatric Hodgkin s lymphoma (PHL).For 10 patients, the planning target volume PTV1 was based on initial CT tumor extension and PTV2 on anatomy-related PET-positive lymph node levels after chemotherapy. The treatment techniques investigated (prescribed dose 19.8 Gy) comprised opposed-field (2F), intensity-modulated photon (IMXT), and single-field (PS) proton techniques. Treatment concepts were compared concerning dose-volume histogram (DVH) parameters and organ-equivalent doses (OED).The median PTV1 and PTV2 were 902? ?555 cm3 and 281? ?228 cm3. When using PTV2 instead of PTV1 for all techniques, the D2% of the heart was reduced from 14 to 9 Gy and the Dmean of the thyroid from 16.6 to 2.7 Gy. Low- (20%), median- (50%), and high-dose volumes (80%) were reduced by 60% for the heart and bones using PTV2. PS reduced the high-dose volume of the lungs and the heart by up to 60%. IMXT increased the low-dose volumes and OED. PTV2 reduced OED by 54? ?10% for all organs at risk.PTV2 has a high impact on the treated volume and on sparing of organs at risk. The combination of an adaptive target volume definition with protons could contribute to future PHL treatment concepts.

(PDF emailed within 0-6 h: $19.90)

Accession: 036697788

Download citation: RISBibTeXText

PMID: 23161118

DOI: 10.1007/s00066-012-0235-8


Related references

(P124) dosimetric comparison of three-dimensional conformal proton radiotherapy and intensity-modulated proton therapy for treatment of pediatric hodgkin lymphoma. Oncology 29(4 Suppl 1): -, 2015

Proton Therapy for Pediatric Hodgkin Lymphoma. Pediatric Blood & Cancer 63(9): 1522-1526, 2016

Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients. International Journal of Radiation Oncology, Biology, Physics 81(4): E667-E671, 2012

Proton therapy in a pediatric patient with stage III Hodgkin lymphoma. Acta Oncologica 52(3): 592-594, 2013

Improved treatment results of children with B-cell non-Hodgkin lymphoma: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study. Pediatric Blood & Cancer 61(7): 1215-1221, 2014

Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric Blood & Cancer 63(10): 1794-1799, 2016

Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatric Blood & Cancer 60(9): 1458-1463, 2013

Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry. Acta Oncologica 55(11): 1378-1380, 2016

Post-treatment PET-CT Rather than Interim PET-CT Using Deauville criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: a Prospective Study Comparing PET-CT versus Conventional Imaging. Journal of Nuclear Medicine, 2016

Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol. European Journal of Haematology 77(5): 365-371, 2006

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Journal of Clinical Oncology 23(30): 7555-7564, 2005

Proton therapy for Hodgkin lymphoma. Current Hematologic Malignancy Reports 9(3): 203-211, 2015

PET imaging in pediatric Hodgkin's lymphoma. Pediatric Radiology 34(3): 190-198, 2004

The effectiveness of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of non-Hodgkin's lymphoma in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group. Wiadomosci Lekarskie 51 Suppl 4: 72-78, 2000

Proton therapy in the management of non-Hodgkin lymphoma. Leukemia & Lymphoma 56(9): 2608-2612, 2016